Quarterra Hires Jordan Calaguire as Chief Investment Officer
Appointment positions multifamily housing leader for next phase of growth
CHARLOTTE, N.C.,
Calaguire brings over 20 years of real estate investment, development, and operating experience, across multifamily, hospitality, industrial, office, and single-family rental sectors. His expertise across sectors, geographies, and investment vehicles uniquely positions him to lead Quarterra's overall investment strategy, capital formation and allocation activities, investor relations, and portfolio performance.
"Jordan joins Quarterra in an important moment as we seek to optimize our capital deployment," said Quarterra CEO
Prior to joining Quarterra, Calaguire worked as Chief Investment and Development Officer at Kasa Inc., a
"I've always been impressed with Quarterra's ability to develop high quality multifamily communities across the US," Calaguire said. "I'm excited to execute against Quarterra's production build vision for its Emblem communities and support the company's mission of delivering high-quality housing solutions at scale. I look forward to leveraging my broad industry expertise and relationships to steward Quarterra's next phase of growth and deliver on behalf of all of our stakeholders, including residents and the communities in which we operate."
About Quarterra
Quarterra is a real estate investment firm focused on creating long-term value through the development of high-quality multifamily communities nationwide. With 12 regional offices across 20 states, Quarterra combines institutional scale with local market expertise to deliver purposefully designed rental communities in high-growth markets. For more information, visit www.Quarterra.com.
Media Contact
Marlena DeFalco
LinnellTaylor Marketing
[email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/quarterra-hires-jordan-calaguire-as-chief-investment-officer-302801137.html
SOURCE Quarterra
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Anbogen Therapeutics and The University of Tokyo Enter Collaborative Research Agreement to Evaluate ABT-301 Across Multiple Tumor Types, Targeting Accelerated Human Clinical Indication Expansion
- World's First Autonomous Humanoid Tennis Match: GALBOT Robots Complete 100+ Consecutive Rallies
- Shape Memory Medical Secures $10 Million Financing Led by August Global Partners to Advance Aortic Clinical Programs
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share